XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis

Overview of attention for article published in Thrombosis Journal, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 10 X posts from 8 X users, with an upper bound of 5,952 followers.

RT @leonasdad: @CarolineFlintMP @Guardians joined up finkin, but when I say your @GOVUK @DHgovuk @NICEcomms Clot managers r full of shit,…

@CarolineFlintMP @Guardians joined up finkin, but when I say your @GOVUK @DHgovuk @NICEcomms Clot managers r full of shit, they r full of shit https://t.co/NbFRD9Pogd

Understanding rivaroxaban: a study on the long-term effects of an increasingly prevalent DVT treatment http://t.co/JySV3cXvnm

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.